GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Trees Corp (OTCPK:CANN) » Definitions » Debt-to-EBITDA

Trees (CANN) Debt-to-EBITDA : 47.05 (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Trees Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Trees's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $2.14 Mil. Trees's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $15.73 Mil. Trees's annualized EBITDA for the quarter that ended in Dec. 2023 was $0.38 Mil. Trees's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 47.05.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Trees's Debt-to-EBITDA or its related term are showing as below:

CANN' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -10.92   Med: -0.42   Max: -0.18
Current: -10.92

During the past 13 years, the highest Debt-to-EBITDA Ratio of Trees was -0.18. The lowest was -10.92. And the median was -0.42.

CANN's Debt-to-EBITDA is ranked worse than
100% of 657 companies
in the Drug Manufacturers industry
Industry Median: 1.69 vs CANN: -10.92

Trees Debt-to-EBITDA Historical Data

The historical data trend for Trees's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trees Debt-to-EBITDA Chart

Trees Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.21 -0.74 -1.54 -4.20 -10.92

Trees Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.30 -6.53 -6.73 -113.57 47.05

Competitive Comparison of Trees's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Trees's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trees's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Trees's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Trees's Debt-to-EBITDA falls into.



Trees Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Trees's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.144 + 15.734) / -1.638
=-10.91

Trees's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.144 + 15.734) / 0.38
=47.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Trees  (OTCPK:CANN) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Trees Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Trees's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Trees (CANN) Business Description

Traded in Other Exchanges
N/A
Address
215 Union Boulevard, Suite 415, Lakewood, CO, USA, 80228
Trees Corp is a vertically-integrated cannabis company and multi-state operator in the United States. It has two segments Retail and Cultivation. It is pursuing a roll-up plan of licensed assets in mature markets while maintaining loyal, local customer bases. TREES owns and operates a light-deprivation greenhouse and a campus of indoor cultivation facilities in Boulder, dispensaries in Englewood, Longmont and Berthoud, Colorado and three dispensaries in Portland, Oregon.
Executives
Carl J Williams director 10 GLENLAKE PARKWAY, NORTH TOWER, ATLANTA GA 30189
Richard C. Travia director 6565 E. EVANS AVENUE, DENVER CO 80224
Allyson Feiler Downing director 3556 W 62ND AVENUE, DENVER CO 80221
Timothy Earl Brown director, 10 percent owner 2301 W 30TH AVENUE, DENVER CO 80211
Diane Jones officer: CHIEF FINANCIAL OFFICER 6565 E. EVANS AVENUE, DENVER CO 80224
Seth Oster director C/O GENERAL CANNABIS CORP, 6565 EAST EVANS AVENUE, DENVER CO 80224
Mark D. Green director C/O GENERAL CANNABIS CORP, 6565 EAST EVANS AVENUE, DENVER CO 80224
Peter Boockvar director C/O MILLER TABAK + CO.,, 331 MADISON AVENUE, NEW YORK NY 10017
John Barker Dalton director, 10 percent owner 6565 E. EVANS AVENUE, DENVER CO 80224
Adam Hershey 10 percent owner 140 RIVERSIDE BOULEVARD, APT 2302, NEW YORK NY 10069
Hershey Strategic Capital, Lp 10 percent owner C/O HERSHEY STRATEGIC CAPITAL GP, LLC, 6 POMPANO ROAD, RUMSON NJ 07760
Hershey Management I, Llc. 10 percent owner 888 7TH AVENUE, 17TH FLOOR, NEW YORK NY 10019
Hershey Strategic Capital Gp, Llc 10 percent owner 888 7TH AVENUE, 17TH FLOOR, NEW YORK NY 10019
Shore Ventures Iii, Lp 10 percent owner C/O HERSHEY MANAGEMENT IV, LLC, 6 POMPANO ROAD, RUMSON NJ 07760
Hershey Management Iv, Llc 10 percent owner 6 POMPANO ROAD, RUMSON NJ 07760